- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Anna Beavis Highlights Importance of Addressing Gender Gaps in HPV Vaccination
If we don't close the gap in gender differences in HPV vaccination, we will likely see an increase in HPV-related cancers, explained Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.
If we don't close the gap in gender differences in HPV vaccination, we will likely see an increase in HPV-related cancers, explained Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.
Transcript
What consequence will we see if gender differences in HPV vaccination are not addressed?
If we don’t close the gap in the HPV vaccination disparity that we see by gender in the United States, then we’ll likely still see a reduction in cervical cancer, but not as big a reduction we could see if we vaccinated both boys and girls. For both boys and girls, cancer of the mouth and throat, as well as anal cancers, that are associated with HPV, those will continue to increase. We’re already seeing an increase in those HPV-related cancers, especially in boys.
Are there any efforts you see right now aimed at closing these gaps?
Yes. There are a multitude of efforts. Some are at the state level, some are at the healthcare system level, some at the physician level, and others are at the community level. I think it’s going to take a very diverse and varied approach at all of these levels in order to improve vaccination rates.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America
May 6th 2024CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.
Read More
